Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
AIxCrypto Holdings ( (AIXC) ) has issued an announcement.
On February 10, 2026, AIxCrypto Holdings, Inc. formalized an advisor agreement effective October 2, 2025 with Yueting (YT) Jia as chief advisor, with a three-year term, substantial cash compensation and significant RSU and PSU grants tied to long-term performance and intellectual property assignment to the company. On the same date, the company executed an employment agreement effective October 2, 2025 with Co-CEO Jiawei Wang that sets pay, bonus eligibility, equity incentives and robust severance and acceleration protections, while separately amending a 2025 stay agreement with Co-CEO Kevin A. Richardson II to increase his compensation and expand his oversight to the pharmaceutical unit, and confirming a part-time CFO agreement for Koti Meka, who will split his time with Faraday Future, underscoring an aggressive effort to secure and incentivize top leadership while aligning them with shareholder value and multi-segment growth plans.
Spark’s Take on AIXC Stock
According to Spark, TipRanks’ AI Analyst, AIXC is a Underperform.
Qualigen Therapeutics’ overall stock score is low due to significant financial challenges, including declining revenue, substantial losses, and financial instability. The bearish technical analysis further dampens the outlook. However, recent corporate events like strategic investments and leadership changes provide a slight positive outlook on future potential improvements.
To see Spark’s full report on AIXC stock, click here.
More about AIxCrypto Holdings
AIxCrypto Holdings, Inc. operates at the intersection of artificial intelligence, digital assets and Web3, focusing on Real World Asset and Embodied AI ecosystem development, AI agents and Web3 AI devices, and AI-driven digital asset management. The company also maintains a pharmaceutical business line, indicating a diversified portfolio across advanced technology and life sciences markets.
Average Trading Volume: 96,899
Technical Sentiment Signal: Sell
Current Market Cap: $6.71M
For an in-depth examination of AIXC stock, go to TipRanks’ Overview page.